Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Markowitz, Michael ^a   Karve, Sudeep ^b   Panish, Jessica ^a   Candrilli, Sean D ^b   Alphs, Larry ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

Author keywords

Adherence; Health care utilization; Hospitalization; Medicaid; Schizophrenia

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PHARMACY; SCHIZOPHRENIA; SELF CARE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MEDICAID; MEDICATION ADHERENCE; MENTAL HEALTH SERVICES; MIDDLE AGED; PATIENT DISCHARGE; SCHIZOPHRENIA; UNITED STATES;

EID: 84884931736     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-246     Document Type: Article

References (50)

1. National Institute of Mental Health What is schizophrenia? 2012, http://www.nimh.nih.gov/health/publications/schizophrenia/complete-index.shtml#pub, National Institute of Mental Health.
2. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull 1996, 22:413-430. 10.1093/schbul/22.3.413, 8873293.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64:1123-1131. 10.1001/archpsyc.64.10.1123, 17909124.
4. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009, 35:383-402. 10.1093/schbul/sbn135, 2659306, 19011234.
5. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150:1115-1121. 10.1016/j.ahj.2005.02.007, 16338246.
6. Liao CH, Chang CS, Wei WC, Chang SN, Liao CC, Lane HY, Sung FC. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study. Schizophr Res 2011, 126:110-116. 10.1016/j.schres.2010.12.007, 21216567.
7. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005, 66:1122-1129. 10.4088/JCP.v66n0906, 16187769.
8. Harrow M, Jobe TH, Faull RN. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychol Med 2012, 42(10):2145-2155. doi:10.1017/S0033291712000220, 10.1017/S0033291712000220, 22340278.
9. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull 2005, 31(3):723-734. 10.1093/schbul/sbi026, 16020553.
10. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 2006, 67:453-460. 10.4088/JCP.v67n0317, 16649833.
11. Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 2010, 176:109-113. 10.1016/j.psychres.2009.05.004, 20185182.
12. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002, 40:630-639. 10.1097/00005650-200208000-00002, 12187177.
13. Ascher-Svanum H, Zhu B, Faries DE, Salkever D, Slade EP, Peng X, Conley RR. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 2010, 10:2. 10.1186/1471-244X-10-2, 2817695, 20059765.
14. Doering S, Müller E, Köpcke W, Pietzcker A, Gaebel W, Linden M, Müller P, Müller-Spahn F, Tegeler J, Schüssler G. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull 1998, 24:87-98. 10.1093/oxfordjournals.schbul.a033316, 9502548.
15. Lin HC, Lee HC. The association between timely outpatient visits and the likelihood of rehospitalization for schizophrenia patients. Am J Orthopsychiatry 2008, 78:494-497.
16. Prince JD, Akincigil A, Kalay E, Walkup JT, Hoover DR, Lucas J, Bowblis J, Crystal S. Psychiatric rehospitalization among elderly persons in the United States. Psychiatr Serv 2008, 59:1038-1045. 10.1176/appi.ps.59.9.1038, 18757598.
17. Johnson B, Montgomery P. Chronic mentally ill individuals reentering the community after hospitalization. Phase II: the urban experience. J Psychiatr Ment Health Nurs 1999, 6:445-451. 10.1046/j.1365-2850.1999.00252.x, 10818867.
18. Melzer D, Hale AS, Malik SJ, Hogman GA, Wood S. Community care for patients with schizophrenia one year after hospital discharge. BMJ 1991, 303:1023-1026. 10.1136/bmj.303.6809.1023, 1671742, 1954452.
19. Olfson M, Marcus SC, Doshi JA. Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry 2010, 71:831-838. 10.4088/JCP.10m05969yel, 20441730.
20. Salokangas RK, Saarinen S. Deinstitutionalization and schizophrenia in Finland: I. discharged patients and their care. Schizophr Bull 1998, 24:457-467. 10.1093/oxfordjournals.schbul.a033340, 9718637.
21. National Committee for Quality Assurance Proposed Measures for HEDIS®1 2013: Schizophrenia 2012, http://www.ncqa.org/Newsroom/2012NewsArchive/NewsReleaseFebruary142012.aspx, National Committee for Quality Assurance.
22. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008, 46:1125-1133. 10.1097/MLR.0b013e31817924d2, 18953222.
23. Leslie R, Gwadry-Sridhar F, Thiebaud P, Patel B. Calculating medication compliance, adherence and persistence in administrative pharmacy claims databases. Pharmaceut Program 2008, 1:13-19.
24. Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009, 43:36-44. 10.1345/aph.1K671, 19126828.
25. Stuart B, Davidoff A, Lopert R, Shaffer T, Samantha Shoemaker J, Lloyd J. Does medication adherence lower Medicare spending among beneficiaries with diabetes?. Health Serv Res 2011, 46:1180-1199. 10.1111/j.1475-6773.2011.01250.x, 3130847,3130847, 21413981.
26. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health 2009, 12:989-995. 10.1111/j.1524-4733.2009.00543.x, 19402852.
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
28. Brook RA, Rajagopalan K, Kleinman NL, Smeeding JE, Brizee TJ, Gardner HH. Incurring greater health care costs: risk stratification of employees with bipolar disorder. Prim Care Companion J Clin Psychiatry 2006, 8:17-24. 10.4088/PCC.v08n0103, 1510906, 16862249.
29. Liu GG, Sun SX, Christensen DB, Zhao Z. Cost analysis of schizophrenia treatment with second-generation antipsychotic medications in North Carolina's Medicaid program. J Am Pharm Assoc 2007, 47:77-81.
30. Basu A, Manning WG. Issues for the next generation of healthcare costs analyses. Med Care 2009, 47(7 Suppl 1):S109-S114.
31. Wedderburn RWM. Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika 1974, 61:439-647.
32. Manning WG, Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 2001, 20:461-494. 10.1016/S0167-6296(01)00086-8, 11469231.
33. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004, 161:692-699. 10.1176/appi.ajp.161.4.692, 15056516.
34. Lang K, Meyers JL, Korn JR, Lee S, Sikirica M, Crivera C, Dirani R, Menzin J. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv 2010, 61:1239-1247. 10.1176/appi.ps.61.12.1239, 21123409.
35. Marcus SC, Olfson M. Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr Bull 2008, 34:173-180. 2632390, 17578893.
36. Sun SX, Liu GG, Christensen DB, Fu AZ. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 2007, 23:2305-2312. 10.1185/030079907X226050, 17697454.
37. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001, 52:805-811. 10.1176/appi.ps.52.6.805, 11376229.
38. Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry 2008, 69:47-53. 10.4088/JCP.v69n0107, 18312037.
39. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004, 55:886-891. 10.1176/appi.ps.55.8.886, 15292538.
40. Centers for Medicare and Medicaid Services Medication therapy management 2012, https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM.html, Centers for Medicare and Medicaid Services.
41. Boyer CA, McAlpine DD, Pottick KJ, Olfson M. Identifying risk factors and key strategies in linkage to outpatient psychiatric care. Am J Psychiatry 2000, 157(10):1592-1598. 10.1176/appi.ajp.157.10.1592, 11007712.
42. Olfson M, Mechanic D, Boyer CA, Hansell S. Linking inpatients with schizophrenia to outpatient care. Psychiatr Serv 1998, 49(7):911-917.
43. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003, 23(4):389-399. 10.1097/01.jcp.0000085413.08426.41, 12920416.
44. Benabarre A, Vieta E, Colom F, Martínez-Arán A, Reinares M, Gastó C. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry 2001, 16(3):167-172. 10.1016/S0924-9338(01)00559-4, 11353595.
45. Harrow M, Grossman LS, Herbener ES, Davies EW. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-inconguent psychotic symptoms. Br J Psychiatry 2000, 177:421-426. 10.1192/bjp.177.5.421, 11059995.
46. Olfson M, Marcus SC, Wan GJ. Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients. Psychiatr Serv 2009, 60(2):210-216. 10.1176/appi.ps.60.2.210, 19176415.
47. Noordsy DL, Phillips GA, Ball DE, Linde-Zwirble WT. Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia. Patient Prefer Adherence 2010, 4:263-271. 2915559, 20694186.
48. Stephenson JJ, Tunceli O, Gu T, Eisenberg D, Panish J, Crivera C, Dirani R. Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians' perceptions of adherence vs. pharmacy claims. Int J Clin Pract 2012, 66(6):565-573. 10.1111/j.1742-1241.2012.02918.x, 3489041, 22574724.
49. Wickizer TM, Lessler D. Do treatment restrictions imposed by utilization management increase the likelihood of readmission for psychiatric patients?. Med Care 1998, 36:844-850. 10.1097/00005650-199806000-00008, 9630126.
50. Wickizer TM, Lessler D, Boyd-Wickizer J. Effects of health care cost-containment programs on patterns of care and readmissions among children and adolescents. Am J Public Health 1999, 89:1353-1358. 10.2105/AJPH.89.9.1353, 1508766, 10474552.